This question arises frequently as more patients begin glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) for type 2 diabetes and weight management
Download high quality TIFF image Many different cell types express GLP-1R and GIPR and utilize G proteins to relay signals, but the impact of incretin binding can have vastly different results in different tissues
Biochem Biophys Res Commun 291:13021308 Yasuda N, Inoue T, Nagakura T et al (2002) Enhanced secretion of glucagon-like peptide 1 by biguanide compounds
Fewer calories mean less available energy unless youre very intentional about how you eat
In ongoing trials at CU Anschutz, Breit helps develop and administer these surveys, which are becoming the foundation for further research
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. New England Journal of Medicine